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Objective. To evaluate the impact of an evidence-based course in complementary medicines on the
attitudes, knowledge, and professional practice behavior of undergraduate pharmacy students.
Design. A required 12-week evidence-based complementary medicine course was designed and in-
troduced into the third-year undergraduate pharmacy curriculum. The course included a combination of
traditional lectures, interactive tutorial sessions, and a range of formal assessments.
Assessment. Pre- and post-course survey instruments were administered to assess changes in students’
attitudes, perceptions, knowledge, and the likelihood they would recommend the use of complementary
medicines in a pharmacy practice environment.
Conclusion. Completion of a required evidence-based complementary medicines course resulted in
a positive change in pharmacy students’ perceptions of the value of various complementary medicines
as well as in their willingness to recommend them, and provided students with the required knowledge
to make patient-centered recommendations for use of complementary medicines in a professional
pharmacy practice setting. These findings support the need for greater evidence-based complementary
medicine education within pharmacy curricula to meet consumer demand and to align with pharma-
cists’ professional responsibilities.
Keywords: complementary medicines, natural health products, evidence-based medicine, pharmacy students,
pharmacy education
INTRODUCTION
There is a significant trend toward increased use of
complementary and alternative medicines or natural
health products in many western countries, including
theUnited States, Canada,UnitedKingdom, andAustralia,
and these produces are now a major component of total
consumer healthcare spending.1-11 Complementary med-
icines (CMs) are available to consumers from many dif-
ferent sources, with community pharmacies having been
identified as one of the most common suppliers, espe-
cially of herbal medicines, nutritional medicines, and vi-
tamin and mineral supplements.10,12,13 In Australia, sales
for CM products account for an estimated 40% of money
spent on all nonsubsidized over-the-counter healthcare
products.5,12 Therefore, community pharmacists are ide-
ally positioned to provide recommendations and guidance
to pharmacy customers about the appropriate use of CMs
and to address the growing range of customer questions
about CM that this increase in use has generated.10,12-14
Studies on consumer attitudes reveal that users of natural
medicines turn to pharmacists for information and ex-
pect them to be able to advise on CMs.10,12,13,15 Ninety-
two percent of Australian pharmacy customers surveyed
believed it was important for pharmacists to provide
safety advice on CMs, and 87% thought pharmacists
should recommendCM if theywere effective.12 The same
study, however, revealed that only 48% of the customers
who used CM believed their pharmacist provided use-
ful CM information about these products.12 While con-
sumers expect pharmacists to be knowledgeable about
CM, research also indicates that many pharmacists lack
confidence in their knowledge or feel they do not have
sufficient training in CM to enable them to meet this
expectation.13,16-20
The problem has not gone unnoticed. Against this
backdrop, the need for greater CM education for pharma-
cists and pharmacy students has already been identified
by other authors.10,11,14,16-25 Such educational initiatives
need to be evidence-based and should address identified
barriers to use, such as a perceived lack of evidence on
safety and efficacy.15,17,22 Evidence-based CM education
within a pharmacy curriculum can also be considered
consistent with the pharmaceutical care educational
outcomes of the American Association of Colleges of
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Pharmacy, which describe a patient-centered approach
that is evidence-based and designed to “maintain pro-
fessional competence by identifying and analyzing
emerging issues, products and services that may impact
patient-specific therapeutic outcomes.”26 Additionally,
the inclusion of CM within pharmacy curricula supports
the standards and guidelines described by the Accredi-
tation Council for Pharmacy Education. This is particu-
larly true of Guideline 12, which focuses on professional
competencies to provide patient care based on therapeu-
tic principles and evidence-based data and to promote
health improvement, wellness, and disease prevention.27
The Australian Pharmacy Council accreditation stan-
dards for curriculum content similarly specify that it
should be patient-focused, address specific patient
needs, and cover a range of topics, including CMs and
the promotion of good health and disease prevention.28
Further, the Australian National Medicine Policy for the
Quality Use of Medicine includes CM in their definition
of “medicines.”29 These factors suggest that pharma-
cists’ professional responsibilities should include pro-
viding advice pertaining to the use of CMs and that, in
the absence of adequate evidence-based knowledge and
training on the subject matter, pharmacists may not be
able to comprehensively fulfill their professional re-
sponsibilities within the broader definition of pharma-
ceutical care.10,18,20
Despite clear recognition of the need for CM training
for pharmacists and several strong arguments in favor of
greater CM education within pharmacy curricula, the lit-
erature suggests that many colleges and schools of phar-
macy, both internationally and in Australia, have not yet
taken the initiative to embed this subject matter into their
core curriculum.10,11,14,18-25 In the absence of clear for-
mal guidelines on CM course content, appropriate course
structure, and suitable teaching methods, the range and
scope of what is taught to pharmacy students about CM
also appear to differ among colleges and schools of phar-
macy and in different countries.10,11,14,19,20,22-25
Recognition of the need for greater CMeducation for
pharmacy students has thus been established. Challenges
facing pharmacy educators in introducing new or adapt-
ing existing CM courses include determining what to
teach; how best to teach the topic, including course struc-
ture (elective, core, or incorporated into other course),
delivery structure, assessment format, and suitable re-
sources; and in assessing whether these initiatives have
been successful in achieving student learning outcomes.
This paper describes the development and implemen-
tation of an evidence-based core curriculum course on CM
to third-year pharmacy students at an Australian university.
The course focused primarily on herbal medicines and
nutritional or dietary supplements, although a brief over-
view of other CMmodalities was also included. The impact
of this course on the students’ attitudes, knowledge, and the
likelihood that they would recommend complementary
medicines to pharmacy customerswere evaluated bymeans
of pre- and post-course surveys conducted with the 2010
and 2011 student cohorts.
DESIGN
A course entitled Evidence-Based Complementary
Medicines was developed and introduced as a core course
into the second semester of the third-year pharmacy cur-
riculum at Curtin University, Australia. There were 125
students enrolled in the course in 2010 and 109 students in
2011. The course was designed to provide students with
the understanding, knowledge, and skills required to as-
sess the merits of the use of CMs within the context of
a community or hospital pharmacy, allowing them to in-
corporate CM into their overall pharmaceutical care plan
and to support a patient-centered, evidence-based ap-
proach. A course objectivewas that the pharmacy students
should be able to apply their knowledge and demonstrate
competence in recommending patient-specific CMs to
promote health, wellness, and disease prevention where
appropriate, taking into consideration the best available
evidence on safety, efficacy, and how they should be used.
A further objective was that the course would enable stu-
dents to confidently communicate with patients and other
health professionals about the use of CMs. Another ex-
pected outcome was that by the end of the course, the
studentswould be able to demonstrate an ability to evaluate
and interpret the clinical literature on a range of CMs, in-
cluding analysis of conflicting evidence-based data.
The course consisted of traditional faculty-led, face-
to face lecture time, delivered 2 hours per week for 12
weeks. This portion of the course was augmented by 6
hours of interactive student-driven tutorials, delivered to
small groups in three 2-hour blocks over the same period,
for a total of 30 hours over the semester. The formal
lectures were supported by the use of an audiovisual re-
cording of each lesson, which was uploaded to Black-
board (Blackboard Inc., Washington, DC), an online
learning environment. A combination of assessment in-
struments was used, including a formal examination,
a midsemester multiple-choice test, and an evidence-
based case study report. The instruments also included
a practical assignment that involved the review and sub-
sequent oral and written presentation on the evidence for
using a specific functional food, supported by demonstra-
tion of the practical use of the ingredient by incorporating
it into a recipe. For this course, the definition for “com-
plementary medicines” described by the Therapeutic
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GoodsAdministration (Australia’s regulatory authority for
therapeutic goods)was used,which states that complemen-
tary medicines include medicinal products containing
herbs, vitamins, minerals, and nutritional supplements,
homoeopathic medicines, and certain aromatherapy prod-
ucts, as well as some others, such as traditional Chinese,
Ayurvedic, and Australian indigenous medicines.30
The first block of lectures introduced complemen-
tary and alternative medicines and their underlying prin-
ciples and philosophies aswell as an overviewof different
forms of complementary and alternative medicines, in-
cluding differentiation between how the terms “comple-
mentary” and “alternative” medicines were to be applied
within the course. The concept of evidence-based medi-
cine was introduced with a discussion of how it could be
applied to CMs, acknowledging the inherent limitations
of applying evidence-based concepts to CMs. Specific
safety and Therapeutic Goods Administration regulatory
issues relating to the use of CMs compared to those of
pharmaceutical medications were also addressed. Two
lectures focused on the chemical constituents of medici-
nal plants and drew correlations between pharmaceutical
chemistry and herbal chemistry. One lecture focused spe-
cifically on Aboriginal bush medicine.
Thereafter, the lecture content focused on the evi-
dence for use of an extensive range of both nutritional
and herbal medicines for various indications. Emphasis
was placed on teaching the evidence pertaining to dietary
products, vitamins, and nutritional and herbal medicines.
These forms of natural medicines have the greatest prac-
tical implications for the students in their future profes-
sion as pharmacists, as they represent the CM products
most commonly sold in a pharmacy setting.12,20 Greater
time was spent on herbal medicines than on nutritional
therapies, given that the pharmacy students had already
received introductory instruction on vitamins and min-
erals as part of a different course in the second year of
the curriculum.
For each nutritional and herbal medicine covered,
evidence-based information was presented using the Nat-
ural Standard Professional database grading system to
reflect the level of scientific evidence for or against each
therapy for specific indications.31 Curtin University li-
brary subscribed to the Natural Standard Professional da-
tabase as a support tool for the introduction of this course.
The pharmacy students were encouraged to access the
database to supplement their lecture material and prepare
for written assignments and to use their prescribed text-
book, Herbs and Natural Supplements: An Evidence-
Based Guide, 3rd Edition.32 The lecture material also
covered specific evidence-based studies, including dis-
cussion on current controversies or regarding conflicting,
limited, or negative evidence for use of a specific CM.
Faculty members attempted to avoid presenting in a bi-
ased manner and to encourage students to critically eval-
uate the evidence and form their own opinions. In
addition, safety data were included for each selected
CM, such as adverse effects, warnings, precautions, con-
traindications, and integrative interactions of theCMwith
pharmaceutical medicines. Proper use of the CMs in ther-
apy and relevant practice points were also included, as
well as proposed or demonstrated pharmacologicalmech-
anisms of action. The final lectures for this course
addressed use of CMs for specific patient groups, such
as pregnant women, preoperative patients, and cancer pa-
tients, and focused on the concept of integrative medicine
and the potential role of the pharmacist in this growing
paradigm.
The tutorial sessions were designed to support the
lecture material in a more practical way, as well as to
provide a wider perspective of both complementary and
alternative medicine modalities that the pharmacist may
encounter. The first tutorial provided the opportunity for
practical, hands-on activities with a range of different
modalities, including herbal medicines, nutritional med-
icines, flower essences, homeopathy, and naturopathic
diagnostic techniques. The second tutorial focused on
the use and practical application of functional or thera-
peutic foods, with students giving a brief oral presentation
on the specific therapeutic foods they had researched,
followed by the sharing of food they had prepared incor-
porating their respective therapeutic ingredients. The
third tutorial integrated knowledge gained throughout
the semester, using practical case study scenarios. The
overall course structure is presented in Table 1.
EVALUATION AND ASSESSMENT
Traditional assessmentmeasures used in this course
include a midsemester, multiple-choice test, a final ex-
amination paper, and written evidence-based reports.
Students were graded according to a rubric, which had
been distributed at the start of the semester with the
assignment guidelines. Qualitative and quantitative
feedback on the students’ perceptions of their learning
experience in this course were gathered and reported by
Curtin University, indicating that student satisfaction
was above both health-science faculty and university
averages.
To assess the impact of the course on the third-year
pharmacy students, a survey instrument was developed
and administered to the students in the first and last les-
son of the Evidence-Based Complementary Medicines
course. This surveywas conducted in the second semester
of 2010, the first year that the course was implemented,
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and to the second student cohort during the second semes-
ter of 2011. The questionnaire, which was administered
before and again after completion of the course, consisted
of a range of questions designed primarily to collect data
on the students’ attitudes and perceptions about CMs and
their willingness to recommend them within in a profes-
sional context. Questions from similar survey instruments
conducted by other investigators were adopted and adap-
ted for use in this study along with additional relevant
questions.15,22,23 A 5-point Likert rating scale was used
for the sections of the survey instrument that focused on
various aspects relating to the students’ attitudes and per-
ceptions toward CMs. Demographic questions were in-
cluded in both the 2010 and 2011 survey instruments, and
a qualitative question that asked students to summarize
their impression of the value of the course was added to
the 2011 postcourse survey instrument.
Ethics approval for this research project was obtained
from Curtin University prior to distribution of the survey
instruments. Participation was voluntary and responses
were anonymous. In 2010, 100 students responded to the
precourse questionnaire, and 80 students responded to the
postcourse questionnaire, whereas in 2011, 78 students
responded to the precourse questionnaire and 57 students
responded to the postcourse questionnaire. The variation in
sample size can be attributed to differences in class atten-
dance rates in the first compared with the last lesson of the
semester, rather than a higher number of nonrespondents to
the postintervention survey instruments or a difference in
response rates between the 2010 and 2011 student cohorts.
Responses on the 5-point Likert scale were scored on
a continuous scale, and mean and standard deviations of
scores for each questionwere calculated. Because student
responseswere gathered anonymously, responses belong-
ing to the same student pre- and post-course were not
identifiable. Therefore, changes from baseline to post-
course were conducted by comparing the means of the
responses for each question using the (independent) stu-
dent’s t test. Using this conservative approach, the signif-
icance of changes was underestimated and some changes
may have been missed, but any changes that appear sig-
nificant are likely to be real. Significance for differences
between groups in all analyses was set at p,0.05. The
data were analyzed using the IBMSPSS Statistics version
18 (2010) and version 20 (2011) software packages (IBM
SPSS, Chicago, IL).
Survey results demonstrated that prior to the course,
the majority of pharmacy students had a positive attitude
Table 1. Course Outline for a Required Course in Evidence-Based Complementary Medicine (CM)
Date Lecture Topic (2 hours per week)
Tutorial Topic (2 hours 3 3
per semester per tutorial group)
Week 1 Introduction to CM and evidence-based medicine; CM safety and
interactions, legislation and regulation of CM in Australia




Week 3 Medicinal plant constituents
Week 4 Evidence-based nutritional medicine (therapeutic use of selected
vitamins and minerals)
Week 5 Evidence-based nutritional medicine (essential fatty acids, selected
antioxidant nutrient supplements, glucosamine and chondroitin)
Functional /therapeutic foods
Week 6 Evidence-based nutritional medicine (probiotics, prebiotics, sports
supplements, 5-HTP, SAMe, melatonin)
Week 7 Evidence-based herbal medicine in CNS disorders
Week 8 Evidence-based herbal medicine in immunity and infection
Week 9 Evidence-based herbal medicine in cardiovascular disorders and
in arthritis
Week 10 Evidence-based herbal medicine in gastrointestinal tract and
endocrine disorders
Practical case scenarios
Week 11 Evidence-based herbal medicine in male and female reproductive
disorders
Week 12 Therapeutic management of specific patient groups including
pregnancy, cancer and pre-operative care; integrative medicine
and pharmacists
Abbreviations: CNS5central nervous system
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toward CMs as a component of a pharmacist’s profes-
sional competence (Table 2). Of the 100 students in
2010 and 78 students in 2011 who completed the initial
precourse questionnaire, 97% (2010) and 99% (2011) in-
dicated that they believed that knowledge about CMs
would be required as part of their future practice as a phar-
macist. The precourse survey instrument also revealed
that 94% (2010) and 95% (2011) of the students believed
that pharmacists have a professional responsibility to ad-
vise patients on the safe, effective, and rationale use of
CMs, with 87% (2010) and 88% (2011) of students
wanted to incorporate CMs into their practice as future
pharmacists, as indicated by a response of either “agree”
or “strongly agree” to each of these survey statements.
The next series of questions focused on the personal
attitudes and beliefs held by the pharmacy students about
CMs (Table 3). Survey results show a significant positive
postcourse change toward a belief that there is evidence
for a number of CMs for the treatment of several condi-
tions and diseases, and for symptom management (2010,
p50.002; 2011, p50.027), and that there is scientific ev-
idence to support the efficacy ofmanyCMsbeyond that of
a placebo effect (2010, p50.002). Therewas also a signif-
icant shift in students’ personal confidence in making
recommendations to patients as part of the pharmaceuti-
cal care provided as a pharmacist (2010, p,0.001; 2011;
p,0.001) as well as in respect for patients’ right to make
informed choices between conventional and complemen-
tary or alternative medicine (2010, p50.003).
The next set of questions explored the likelihood of
recommending the use of CMs for various conditions or
disease states commonly seen by pharmacists, based on
the attitudes, perceptions, and knowledge of the phar-
macy students before and after the CM course. For the
purpose of this set of questions, use could be for prophy-
laxis or for treatment and could be as either primary or
adjunct therapy, as appropriate. The 20 conditions that
were included in the survey instrument were depression
(mild-moderate and moderate-severe), anxiety/stress, in-
somnia, fatigue, Alzheimer’s disease/dementia, migraine
prophylaxis, osteoarthritis, rheumatoid arthritis, meno-
pausal symptoms, benign prostatic hypertrophy, sexual
dysfunction, cold and flu prophylaxis, cold and flu treat-
ment, nausea, irritable bowel syndrome, minor cuts/
abrasions, hypertension, hyperlipidemia, and diabetes. A
comparison of pre- and post-course responses indicated
a positive change toward a greater willingness to recom-
mend CMs for all listed conditions and disease states fol-
lowing completion of the evidence-based course. This was
especially notable within the 2010 student cohort, for
which the change was significant with respect to the ma-
jority of conditions included in the questionnaire.
An additional set of questions investigated the stu-
dents’ likelihood of recommending a specific CM based
on their knowledge of CMs before and after completing
the course. Selection of the CMs in this section of the
questionnaire was based on 20 examples of herbal and
nutritional medicines covered in the course, including:
St. John’s wort, feverfew, ginkgo, garlic supplements,
ginger supplements, ginseng, echinacea, andrographis,
black cohosh, saw palmetto, fucus, gymnema, cranberry,
omega-3 fish oils, evening primrose oil, glucosamine,
chondroitin, vitamin C, CoQ10, and probiotics. For 15 of
the 20 CMs listed on the questionnaire, there were post-
course positive changes in attitude and likelihood of use,
most ofwhichwere significant across both student cohorts.
A significant negative change was demonstrated for
2 of the complementary medicines: evening primrose oil
(2010 and 2011, p,0.001) and vitaminC (2010 and 2011,
p,0.001), with students indicating they were less likely
to recommend these products after the course than before.
Compared with student perceptions prior to the course,
this outcome can be considered favorable, given that these
2 products are examples of CMs commonly sold in phar-
macies, but for which there is relatively less scientific
evidence to support widespread use. There was almost no
Table 2. Changes in Students’ Attitudes Toward Complementary Medicine After Completion of a Required Course in Evidence-
Based Complementary Medicine (CM)
Student Precourse Postcourse
Statement About Professional Competence as a Pharmacist Cohort No. Mean (SD) No. Mean (SD) P
Knowledge about complementary and alternative medicine
will be required in my future practice of pharmacy.
2010 100 4.5 (0.1) 80 4.5 (0.1) 0.98
2011 78 4.7 (0.1) 57 4.6 (0.1) 0.69
I believe pharmacists have a responsibility to advise patients
on the safety concerns pertaining to CMs.
2010 100 4.5 (0.1) 80 4.5 (0.1) 0.96
2011 78 4.6 (0.1) 57 4.6 (0.1) 0.87
I believe pharmacists have a responsibility toward their patients
on the rational and effective use of CMs.
2010 100 4.3 (0.1) 80 4.4 (0.1) 0.40
2011 77 4.5 (0.1) 57 4.6 (0.1) 0.44
Pharmaceutical care should integrate the best of conventional
and CMs.
2010 100 4.1 (0.1) 78 4.2 (0.1) 0.76
2011 76 4.1 (0.1) 56 4.4 (0.1) 0.02
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change in the likelihood of students recommending cran-
berry, omega-3 fish oils, or glucosamine pre- and post-
course across both student cohorts. This finding can be
attributed to students having a positive baseline attitude
for each of these 3 products. Table 4 presents selected ex-
amples of the impact of the course on pharmacy students’
willingness to recommend CMs following the course.
The evidence-based CM course had a positive im-
pact on students’ attitudes, perceptions, and willingness
to recommend CMs. These findings were further sup-
ported by qualitative feedback, which demonstrated
that the pharmacy students saw merit in learning about
evidence-based CMs to prepare them for future careers as
pharmacists and that this CM course had equipped them
with the knowledge and confidence to make CM recom-
mendations in a pharmacy. Examples of these qualitative
statements include: “A very valuable unit. CM is a huge
part of pharmacy and it’s important to have knowledge in
this area”; “It has providedmewith valuable knowledge to
better my patient counselling and CM recommendations”;
and “This unit has enabled me to make evidence-based
recommendations to patients regarding CM indications,
safety and efficacy.”
DISCUSSION
Although CM has been integrated into pharmacy
education in Australia, the development of this course
was innovative in that it was the first core curriculum
course specifically focused on evidence-based CM to be
introduced into an undergraduate pharmacy curriculum in
Australian universities. The quantitative results of the
precourse and postcourse survey instruments for both
2010 and 2011 revealed that the course positively changed
the majority of the pharmacy students’ attitudes and be-
liefs regarding use of CMs and increased the likelihood
that they would recommend a variety of CMs in their
capacity as pharmacists. The findings also suggest that
after completing the course, students were able to discern
when use of CMs was suitable and rational, based on
evidence, and the appropriateness of use for certain dis-
ease states or conditions.
The postcourse qualitative data collected from the
2011 survey instruments highlight the perceived value
of the course by the studentswith respect to its importance
within the curriculum and its ability to equip them with
the knowledge and skills required to enable them to make
appropriate CM recommendations in a pharmacy setting.
The 2010 and 2011 data indicate that prior to the
course, the majority of the students believed that knowl-
edge of CM was an important pharmacy practice com-
petence and that pharmacists have a professional
responsibility to be able to advise pharmacy customers
on the safe, rational, and effective use of CMs. This
positive precourse attitude explains why a comparison
of pre- and post-course responses showed no significant
change for the first series of attitudinal questions relating
Table 3. Changes in Students’ Personal Attitudes Toward Complementary Medicine After Completion of a Required Course in
Evidence-Based Complementary Medicine
Student Precourse Postcourse
Statement About Personal Attitudes and Beliefs Cohort No. Mean (SD) No. Mean (SD) P
I believe that there are limitations to conventional
approaches in health care.
2010 99 3.7 (0.1) 79 3.9 (0.1) 0.28
2011 76 3.8 (0.1) 57 4.1 (0.1) 0.04
A number of CMs hold promise for the management
of symptoms, conditions and/or disease.
2010 99 3.8 (0.1) 79 4.1 (0.1) 0.002
2011 78 3.9 (0.1) 57 4.2 (0.1) 0.027
I believe there is insufficient evidence on the safety,
efficacy and mechanism of action of most CMs to
be able to make recommendations about their use.
2010 99 3.2 (0.1) 80 3.0 (0.1) 0.13
2011 78 3.3 (0.1) 57 3.4 (0.1) 0.62
The results of CMs are, in most cases, due to a placebo
effect.
2010 100 2.9 (0.1) 80 2.5 (0.1) 0.002
2011 78 3.1 (0.1) 57 3.2 (0.1) 0.68
I believe that patients should have the right to choose
between conventional and alternative approaches in
health care.
2010 100 3.9 (0.1) 80 4.3 (0.9) 0.003
2011 78 4.2 (0.1) 57 4.4 (0.1) 0.11
I hope to be able to incorporate CM into my practice as
a pharmacist.
2010 99 4.3 (0.1) 80 4.3 (0.1) 0.69
2011 78 4.3 (0.1) 57 4.4 (0.8) 0.24
I am confident in my ability to provide pharmaceutical
care to patients using CMs.
2010 100 2.5 (0.1) 80 3.5 (0.1) ,0.001
2011a 43 2.7 (0.2) 40 3.7 (0.1) ,0.001
Abbreviations: CM 5 complementary medicine.
a Response rates for this question were lower in the 2011 survey because the Likert rating scale for this item was inadvertently omitted from the
questionnaire.
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to pharmacy professional competence (Table 2). Of the
students who completed the precourse survey instrument,
69% of the 2010 student cohort and 60% of the 2011 stu-
dent cohort were already working in a pharmacy, which
likely influenced their positive attitudes toward CMs as
they pertain to community pharmacists. In addition, the
student cohorts were ethnically diverse, with 52% of the
2010 group and 60% of the 2011 group reporting that CMs
were an important part of their family culture.
Therewas a positive change in personal attitudes and
beliefs of students in both cohorts toward complementary
medicines after completion of the course,with this change
being significant for many of the questions in this section
(Table 3). Therewas a greater change in personal attitudes
toward CM after the course than the amount of change
seen in professional competence attitudes after the course.
This finding suggests that themajority of students already
perceived knowledge about CMs to be an important
professional requirement prior to the course; however,
many may have been personally skeptical about the use
of CMs in a pharmacy setting prior to the course.
The course material adopted a scientific focus, ad-
dressing the evidence to both support and, in some circum-
stances, refute the use of specific CMs sold by pharmacies.
Areas of controversy were highlighted and students were
encouraged to critically evaluate the literature. We believe
this approach was instrumental in bringing about such pos-
itive changes in the students’ personal attitudes and beliefs
aboutCMs and significantly increased their’ self-confidence
regarding their ability to provide pharmaceutical care to
pharmacy customers and patients using CMs.
The results of the survey instruments in both 2010
and 2011 showed that after completing the course, stu-
dents were significantly more likely to recommend a CM
Table 4. Changes in Student Attitudes Toward Use of Specific Complementary Medicines After Completion of Required Course in
Evidence-Based Complementary Medicine
Student Precourse Postcourse
Item Cohort No. Mean (SD) No. Mean (SD) P Changea
Would recommend use of St John’s wort 2010 100 2.8 (0.1) 80 3.6 (0.1) ,0.001 [
2011 78 3.0 (0.1) 57 3.6 (0.2) 0.002 [
Would recommend use of ginger supplements 2010 100 3.6 (0.1) 80 4.0 (0.1) 0.003 [
2011 77 3.9 (0.1) 57 4.1 (0.1) 0.041 [
Would recommend use of ginseng 2010 100 3.6 (0.1) 80 4.0 (0.1) 0.003 [
2011 76 3.7 (0.1) 57 4.1 (0.1) 0.001 [
Would recommend use of andrographis 2010 100 2.8 (0.1) 80 3.8 (0.1) ,0.001 [
2011 76 3.0 (0.1) 57 4.3 (0.1) ,0.001 [
Would recommend use of black cohosh 2010 100 2.8 (0.1) 80 4.1 (0.1) ,0.001 [
2011 77 2.9 (0.1) 57 4.4 (0.1) ,0.001 [
Would recommend use of saw palmetto 2010 99 2.9 (0.1) 80 3.7 (0.1) ,0.001 [
2011 78 2.9 (0.1) 57 3.8 (0.1) ,0.001 [
Would recommend use of chondroitin 2010 100 4.0 (0.1) 80 4.5 (0.1) 0.001 [
2011 77 3.7 (0.1) 57 4.4 (0.1) ,0.001 [
Would recommend use of CoQ10 2010 100 3.9 (0.1) 80 4.4 (0.1) 0.002 [
2011 78 4.0 (0.1) 57 4.5 (0.1) 0.003 [
Would recommend use of cranberry 2010 100 4.1 (0.1) 80 4.1 (0.1) 0.97 -
2011 78 4.3 (0.1) 57 4.4 (0.1) 0.72 -
Would recommend use of omega-3 fish oils 2010 100 4.6 (0.1) 80 4.6 (0.1) 0.72 -
2011 77 4.7 (0.1) 57 4.8 (0.1) 0.74 -
Would recommend use of glucosamine 2010 100 4.4 (0.1) 79 4.5 (0.1) 0.14 -
2011 78 4.3 (0.1) 57 4.5 (0.1) 0.16 -
Would recommend use of evening primrose oil 2010 99 3.9 (0.1) 80 3.1 (0.2) ,0.001 Y
2011 77 4.0 (0.1) 57 3.0 (0.2) ,0.001 Y
Would recommend use of vitamin C 2010 100 4.3 (0.1) 80 3.8 (0.1) ,0.001 Y
2011 78 4.3 (0.1) 57 3.6 (0.2) 0.001 Y
a Change in likelihood of use of this CM after the course: [ 5 significantly more likely to recommend a specific CM after completion of the
evidence-based course; - 5 no significant change; Y 5 significantly less likely to recommend a specific CM after completion of the evidence-
based course.
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formost of the conditions listed in the survey instruments.
Likewise, analysis of the 2010 and 2011 responses
showed that the pharmacy students were more likely
to recommend most of the CMs listed in the survey in-
strument following the course. These findings suggest
that the evidence-based CM education in our course
positively changed students’ professional practice be-
havior with regard to a range of conditions and a range
of products.
The design and findings of our studywere similar in
many respects to those reported by Evans and Evans in
2006, wherein survey instruments were used to assess
pharmacy students’ attitudes toward complementary
and alternative medicines before and after a required
course.23 Their study demonstrated that inclusion of
complementary and alternative medicine education in
a pharmacy curriculum influenced students’ attitudes,
perceptions, and the recommendations that they were
willing to make. Many of our survey questions were
adapted from those used by these authors in their pre-
and post-course survey instruments. While one can
draw correlations between these 2 studies, key differ-
ences should be noted. The course content and structure
were significantly different in that our course focused
primarily on evidence to support use of herbal and nu-
tritional medicines sold in pharmacies, whereas the course
evaluated by Evans and Evans included therapies that are
not available or applicable to pharmacies, such asmassage,
chiropractic care, hypnosis, meditation, deep-breathing,
therapeutic touch, Chinese and Ayuverdic medicine, and
homeopathy.23 Additionally, our study followed 2 co-
horts of students over 2 years and had a significantly
higher number of survey respondents (n5178 vs. 55)
with more diverse ethnic, cultural, and demographic
backgrounds than the Evans and Evans’ survey.
Several other authors have also conducted studies
evaluating the impact of CM education on pharmacy
students across various parameters, such as their atti-
tudes, perceptions, knowledge, or confidence regard-
ing CMs.10,11,22,24,25 These CM courses varied in terms
of content, structure, duration, focus, and teaching
methods and had meaningful differences in research
methodology and analyses used, making an accurate
comparison challenging. However, despite these dif-
ferences, there is a consistent theme in outcomes sug-
gesting that appropriate CM education is well received
by pharmacy students and positively influences their
attitudes, confidence, and willingness to recommend
CM to pharmacy customers. This research also sup-
ports the position taken by other investigators who have
highlighted the importance of CM education for phar-
macy students.14,15,20
There are numerous factors that differentiate our
study from previous research conducted in this area. This
study describes the development, introduction, content,
and assessment of the impact of a required evidence-
based CM course, rather than an assessment of the impact
of an elective course or of CM content incorporated into
other required pharmacy courses. This course was
designed with a specific focus on CMs that are relevant
to pharmacy practice and for which there is scientific
evidence to support use. In developing the course, aca-
demic staff also focused on taking a practical, patient-
focused approach that fell within current pharmaceutical
care recommendations. Because our approach to course
content included herbal medicines and nutritional/dietary
supplements, our research investigates the impact of
a range of evidence-based CMs, rather than focusing on
only 1 form of CM in a pharmacy course. Another feature
of our study was that we conducted both pre- and post-
course survey instruments over 2 consecutive years, thus
enhancing the significance of our findings.While various
other studies conducted on pharmacy students and CM
education have addressed some of the elements described
in our study, review of the literature suggests that our
study is unique in addressing all of these components in
a single study.
There were several limitations to our study. Because
our survey responses were not identified with a unique
respondent identification code, it was not possible to link
pre- and post-course responses for each participant.While
this design feature offered the advantage of ensuring all
responses were anonymous, which may have encouraged
participation while still allowing us to assess trends in
changes across the 2010 and 2011 cohorts, it prevented
us from measuring changes in individual students’ atti-
tudes, perceptions, and adoption of CMs. A typographical
error (omission of the Likert rating scale) in 1 question of
the 2011 survey questionnaires resulted in a lower re-
sponse rate for that question. Finally, although the survey
results suggest an increased willingness by the students to
recommendCMs after completion of the course, this find-
ing will not necessarily translate into a sustainable long-
term change in either attitude or competence in making
appropriate recommendations for use of CMs. Further
research into this aspect of our study may be warranted.
Evidence-Based Complementary Medicines is ac-
cepted as a core curriculum course within the bachelor
of pharmacy degree at Curtin University. The course was
taught again in 2012, with all lecture and reading materials
having been updated to reflect changes in available evi-
dence on various CMs, revision of information pertaining
to safety and patient advice, and with new controversies
and areas of topical interest in the literature highlighted.
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SUMMARY
The course in CMwas designed to provide students
with the understanding, knowledge, and skills required
to assess themerits of CMs in the context of a community
or hospital pharmacy, allowing them to incorporate CM
into their overall pharmaceutical care plan and to sup-
port a patient-centered, evidence-based approach. The
results of the pre- and post-course survey instruments,
conducted over 2 consecutive academic years indicate
that many of the initial curriculum objectives were met
through the introduction of this course into the under-
graduate pharmacy curriculum. By approaching the sub-
ject matter from an evidence-based perspective with
emphasis on relevance of the CM in a pharmacy setting,
the course proved valuable in supporting pharmacy stu-
dents’ ability to make appropriate patient-specific CM
recommendations as part of their professional pharmacy
practice, taking into consideration evidence on safety,
efficacy, and place in therapy. This outcome aligns with
the pharmaceutical care educational guidelines for phar-
macy students.
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